Overview

Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
Pharmacokinetic study in TB patients to determine the effect of rifampicin on the pharmacokinetic profile of moxifloxacin.
Phase:
Phase 2
Details
Lead Sponsor:
Radboud University
Treatments:
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination